Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006443 · ClinicalTrials.gov registry record · NA
Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques
A NA study of Tricuspid Regurgitation, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05006443 is a NA study of Tricuspid Regurgitation that has completed, run by Mayo Clinic. The registered enrollment target is 75 participants, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05006443, a NA study of Tricuspid Regurgitation, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac Magnetic Resonance
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05006443
The ClinicalTrials.gov registry entry for NCT05006443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 531-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (86% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Magnetic Resonance is the first listed.
NCT05006443 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05006443 about?
NCT05006443 is a clinical study titled "Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques". The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).
What is the current status of trial NCT05006443?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-01-14. Estimated completion is 2025-04-30.
What conditions does trial NCT05006443 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT05006443?
The interventions under investigation include: Cardiac Magnetic Resonance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05006443?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05006443 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.